Added to YB: 2024-03-22
Pitch date: 2024-01-23
DXCM [bullish]
DexCom, Inc.
-43.58%
current return
Author Info
No bio for this author
Company Info
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally.
Market Cap
$27.1B
Pitch Price
$128.10
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.11
P/E
33.71
EV/Sales
5.69
Sector
Health Care Equipment and Supplies
Category
growth
Next Century Growth Investors SMID Cap Growth Strategy New Portfolio holding: DexCom, Inc.
DXCM: Leader in CGM for diabetes, taking share from fingersticks. Improved accuracy, functionality, indications, insulin pump integration, reimbursement & geographic expansion driving strong revenue growth & rising profitability. Set to continue delivering in the future.
Read full article (1 min)